Kyverna Therapeutics logo

Kyverna Therapeutics Funding & Investors

Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases.

kyvernatx.com

Total Amount Raised: $170,000,000

Kyverna Therapeutics Funding Rounds

  • Series B

    $60,000,000

    Series B Investors

    jVen Capital
    GordonMD Global Investments
    Vida Ventures
    RTW Investments
    Bain Capital Life Sciences
    Insight Venture Partners
    LYFE Capital
    Westlake Village BioPartners
    CAM Capital
    Gilead Sciences
    Northpond Ventures
  • Series B

    $85,000,000

    Series B Investors

    Northpond Ventures
    Healthcor Management
    jVen Capital
    Intellia Therapeutics
    LYFE Capital
    Insight Venture Partners
    CAM Capital
    Gilead Sciences
    Vida Ventures
    RTW Investments
    Hudson Bay Capital Management
    Westlake Village BioPartners
    Argentum Group
  • Series A

    $25,000,000

    Series A Investors

    Westlake Village BioPartners
    Vida Ventures
Funding info provided by Diffbot.